Tripathy on Treating HER2+ Breast Cancer With Leptomeningeal Metastasis

Dr Tripathy explains the rationale for the TBCRC049 trial, the challenges of investigating a disease that appears in less than 5% of patients with breast cancer, and potential avenues for future investigations.